|
Delaware
(State or Other Jurisdiction of Incorporation or Organization)
|
| |
20-8185347
(I.R.S. Employer Identification No.)
|
|
|
Brian A. Johnson, Esq.
Wilmer Cutler Pickering Hale and Dorr LLP 7 World Trade Center 250 Greenwich Street New York, New York 10007 Telephone: (212) 230-8800 Fax: (212) 230-8888 |
| |
Todd D.C. Anderman, Esq.
Vice President, General Counsel & Corporate Secretary IVERIC bio, Inc. One Penn Plaza, 35th Floor New York, New York 10119 (212) 845-8200 |
|
|
Large accelerated filer ☐
Non-accelerated filer ☐
|
| |
Accelerated filer ☒
Smaller reporting company ☒
Emerging growth company ☐
|
|
| | ||||||||||||||||||||||||||||
Title of each class of
securities to be registered |
| | |
Amount
to be Registered(1) |
| | |
Proposed Maximum
Offering Price Per Unit(2) |
| | |
Proposed Maximum
Aggregate Offering Price(2) |
| | |
Amount of
Registration Fee |
| ||||||||||||
Common Stock, $0.001 par value per share
|
| | | | | 8,649,453 | | | | | | $ | 4.14 | | | | | | $ | 35,808,735.40 | | | | | | $ | 4,647.97 | | |
| | | | | 1 | | | |
| | | | | 3 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 11 | | | |
| | | | | 15 | | | |
| | | | | 17 | | | |
| | | | | 17 | | | |
| | | | | 18 | | | |
| | | | | 18 | | |
| | |
Shares of Common
Stock Beneficially Owned Prior to Offering |
| |
Number of
Shares of Common Stock Being Offered |
| |
Shares of Common
Stock to be Beneficially Owned After Offering(1) |
| |||||||||||||||||||||
Name of Selling Stockholder
|
| |
Number
|
| |
Percentage
|
| |
Number
|
| |
Percentage
|
| ||||||||||||||||||
Samsara BioCapital, L.P.
|
| | | | 3,370,478(2) | | | | | | 3.8% | | | | | | 2,682,926 | | | | | | 687,552 | | | | | | *% | | |
Vivo Capital Fund IX, L.P.
|
| | | | 1,088,479(3) | | | | | | 1.2% | | | | | | 1,088,479 | | | | | | 0 | | | | | | —% | | |
Vivo Opportunity Fund, L.P.
|
| | | | 4,878,048(4) | | | | | | 5.5% | | | | | | 4,878,048 | | | | | | 0 | | | | | | —% | | |
| | |
Amount
|
| |||
SEC registration fee
|
| | | $ | 4,647.97 | | |
Accounting fees and expenses
|
| | | | 12,500 | | |
Legal fees and expenses
|
| | | | 50,000 | | |
Miscellaneous fees and expenses
|
| | | | 15,000 | | |
Total expenses
|
| | | $ | 82,147.97 | | |
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Glenn P. Sblendorio
Glenn P. Sblendorio
|
| | President, Chief Executive Officer and Director (principal executive officer) | | |
August 6, 2020
|
|
|
/s/ David F. Carroll
David F. Carroll
|
| | Senior Vice President, Chief Financial Officer and Treasurer (principal financial and accounting officer) | | |
August 6, 2020
|
|
|
/s/ David R. Guyer
David R. Guyer, M.D.
|
| | Executive Chairman of the Board of Directors | | |
August 6, 2020
|
|
|
/s/ Mark S. Blumenkranz
Mark S. Blumenkranz
|
| | Director | | |
August 6, 2020
|
|
|
/s/ Axel Bolte
Axel Bolte
|
| | Director | | |
August 6, 2020
|
|
|
/s/ Adrienne L. Graves
Adrienne L. Graves, Ph.D.
|
| | Director | | |
August 6, 2020
|
|
|
/s/ Jane P. Henderson
Jane P. Henderson
|
| | Director | | |
August 6, 2020
|
|
|
/s/ Calvin W. Roberts
Calvin W. Roberts, M.D.
|
| | Director | | |
August 6, 2020
|
|